OptimizeRx (OPRX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

OptimizeRx to Participate in Upcoming Investor Conferences
GlobeNewswireNov 18 07:30 ET
OptimizeRx Corporation (NASDAQ:OPRX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall StNov 16 08:47 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BenzingaNov 14 16:10 ET
OptimizeRx | 10-Q: Q3 2024 Earnings Report
SECNov 14 15:37 ET · Announcements
OptimizeRx Shares Slump After 3Q Results Miss Estimates, Cuts Outlook
WSJNov 14 12:11 ET
OptimizeRx Price Target Lowered to $11 From $15 at Lake Street
TipRanksNov 14 08:46 ET

Comments

Jaguar8

Sep 10 07:09

NEWS

$OptimizeRx (OPRX.US)$
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing ...

Moomoo AI

Mar 15 07:14

Recent insider selling at OptimizeRx, especially by Marion Odence-Ford, may worry potential investors. The absence of insider buying and insignificant share ownership by insiders hint at possible doubts about future performance.

OptimizeRx's Stock Sinks To US$12.92, But Insiders Sold Even Lower

2

Moomoo AI

Dec 21, 2023 06:04

OptimizeRx's high P/S ratio may suggest that investors anticipate a turnaround in the company's revenue performance. This could indicate shareholders' strong future revenue expectations.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 06:01

The high P/S ratio at OptimizeRx suggests investors expect a reversal of the company's downtrend in revenue. Shareholders seem to hold stocks with hope for the company's promising future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 06:01

Investors at OptimizeRx might be anticipating a reversal in its poor revenue performance, hence the high P/S ratio. Shareholders potentially retain stocks expecting the company's bright future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

OPRX OptimizeRx

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target